StonvexLoading…
StonvexStonvexStonvexCore line items from CVNA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-07-28 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $6.98B | $6.43B | $20.32B | $14.72B | $9.07B |
Operating Income | Not available | $581.00M | $1.88B | $1.46B | $905.00M |
Net Income | Not available | $250.00M | $1.41B | $550.00M | $399.00M |
EPS (Diluted) | $0.39 | Not available | $8.45 | Not available | Not available |
Total Assets | Not available | $13.77B | $13.20B | $9.85B | $9.37B |
Total Liabilities | Not available | $9.14B | $9.00B | $6.90B | $7.25B |
Cash & Equivalents | Not available | $2.41B | $2.33B | $2.14B | $1.86B |
Free Cash Flow OCF − CapEx | Not available | $56.00M | $889.00M | $510.00M | $203.00M |
Shares Outstanding | Not available | Not available | 224.28M | Not available | Not available |